Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fibroblast Growth Factor-23 as a Marker of Acute Kidney Injury After Partial Nephrectomy

NCT04693962 is registered in ClinicalTrials.gov with University of Chile as lead sponsor.

NCT NCT04693962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04693962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fibroblast Growth Factor-23 as a Marker of Acute Kidney Injury After Partial Nephrectomy
Lead sponsor
University of Chile
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2017
Completion date
December 1, 2021
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, kidney ischemia